Cowealth Medical China Co.Ltd. (603122) - Total Assets
Based on the latest financial reports, Cowealth Medical China Co.Ltd. (603122) holds total assets worth CN¥1.41 Billion CNY (≈ $206.85 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Cowealth Medical China Co.Ltd. for net asset value and shareholders' equity analysis.
Cowealth Medical China Co.Ltd. - Total Assets Trend (2019–2025)
This chart illustrates how Cowealth Medical China Co.Ltd.'s total assets have evolved over time, based on quarterly financial data.
Cowealth Medical China Co.Ltd. - Asset Composition Analysis
Current Asset Composition (December 2025)
Cowealth Medical China Co.Ltd.'s total assets of CN¥1.41 Billion consist of 78.7% current assets and 21.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.5% |
| Accounts Receivable | CN¥690.03 Million | 48.3% |
| Inventory | CN¥172.64 Million | 12.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥7.00 Million | 0.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Cowealth Medical China Co.Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Cowealth Medical China Co.Ltd. (603122) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cowealth Medical China Co.Ltd.'s current assets represent 78.7% of total assets in 2025, a decrease from 87.2% in 2019.
- Cash Position: Cash and equivalents constituted 7.5% of total assets in 2025, up from 5.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 48.3% of total assets.
Cowealth Medical China Co.Ltd. Competitors by Total Assets
Key competitors of Cowealth Medical China Co.Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB
|
India | Rs31.46 Billion |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$3.10 Million |
|
Check-Cap Ltd.
NASDAQ:MBAI
|
USA | $7.49 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
Cowealth Medical China Co.Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.05 | 3.47 | 4.78 |
| Quick Ratio | 2.59 | 2.93 | 4.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥749.61 Million | CN¥940.96 Million | CN¥1.05 Billion |
Cowealth Medical China Co.Ltd. - Advanced Valuation Insights
This section examines the relationship between Cowealth Medical China Co.Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.12 |
| Latest Market Cap to Assets Ratio | 0.53 |
| Asset Growth Rate (YoY) | -4.4% |
| Total Assets | CN¥1.43 Billion |
| Market Capitalization | $757.80 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cowealth Medical China Co.Ltd.'s assets below their book value (0.53x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Cowealth Medical China Co.Ltd.'s assets decreased by 4.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Cowealth Medical China Co.Ltd. (2019–2025)
The table below shows the annual total assets of Cowealth Medical China Co.Ltd. from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.43 Billion ≈ $209.04 Million |
-4.39% |
| 2024-12-31 | CN¥1.49 Billion ≈ $218.63 Million |
+2.24% |
| 2023-12-31 | CN¥1.46 Billion ≈ $213.85 Million |
-6.26% |
| 2022-12-31 | CN¥1.56 Billion ≈ $228.14 Million |
+39.13% |
| 2021-12-31 | CN¥1.12 Billion ≈ $163.97 Million |
+0.77% |
| 2020-12-31 | CN¥1.11 Billion ≈ $162.72 Million |
-1.60% |
| 2019-12-31 | CN¥1.13 Billion ≈ $165.37 Million |
-- |
About Cowealth Medical China Co.Ltd.
Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers centralized procurement services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company w… Read more